In order to locate amino acid residues involved in the formation of feline calicivirus (FCV) neutralizing epitopes, we analysed the capsid protein gene of monoclonal antibody neutralization-resistant variants of FCV. Amino acid substitutions in the variants were identified in the two hypervariable regions of the capsid protein. Four linear and two conformational epitopes were located in the regions from residues 426 to 460 and 490 to 520, respectively. The relative positions of individual epitopes agreed with our previous antigenic analysis. Two antigenic sites composed of the neutralizing epitopes were mapped in the hypervariable regions of the capsid protein, demonstrating that a relationship exists between the genetic variability and antigenic differences in the neutralization of FCV.
In order to locate amino acid residues involved in the formation of feline calicivirus (FCV) neutralizing epitopes, we analysed the capsid protein gene of monoclonal antibody neutralization-resistant variants of FCV. Amino acid substitutions in the variants were identified in the two hypervariable regions of the capsid protein. Four linear and two conformational epitopes were located in the regions from residues 426 to 460 and 490 to 520, respectively. The relative positions of individual epitopes agreed with our previous antigenic analysis. Two antigenic sites composed of the neutralizing epitopes were mapped in the hypervariable regions of the capsid protein, demonstrating that a relationship exists between the genetic variability and antigenic differences in the neutralization of FCV.
Feline calicivirus (FCV) is a major cause of upper respiratory diseases in cats (Gillespie & Scott, 1973) . Although only one serotype of FCV is presently recognized (Povey, 1974 ; Kalunda et al., 1975) , there are antigenic differences among the isolates of FCV as demonstrated by cross-neutralization tests (Dawson et al., 1993) . The capsid of FCV is considered to play an important role in the antigenic variability of the virus because FCV has only a single capsid protein (Bachrach & Hess, 1973 ; Burroughs & Brown, 1974) . Studies on expression and antigenic analysis of the capsid protein using prokaryotic expression systems have revealed that at least one major neutralizing epitope exists in the region between amino acids 408 and 517 (Guiver et al., 1992) and that two neutralizing monoclonal antibodies (MAbs) bound to a region of 37 amino acids between positions 422 and 458 (Milton et al., 1992) . Recently, variation in the capsid protein gene among FCV isolates has been established by comparative sequence studies Seal et al., 1993 ; Seal, 1994) . The hypervariable regions (amino acids 426 to 460 and 490 to 520) of the capsid protein were identified and suggested to contain the antigenically variable determinants of FCV.
Previously, we identified seven neutralizing epitopes of the F4 strain of FCV with the aid of an extensive panel of neutralizing MAbs and neutralization-resistant variants (Tohya et al., 1990 (Tohya et al., , 1991 . All these epitopes were shown to exist on the capsid protein of the virus by indirect immunofluorescence using the capsid precursor protein produced in a mammalian cDNA expression system (Shin et al., 1993) . In addition, the reactivities of the MAbs with deleted polypeptides, expressed in the same system, were determined and the results suggested that four linear epitopes were related to amino acids 381 and 454 of the capsid protein (Shin et al., 1993) . However, three epitopes were not mapped on the protein because of their conformational nature. Therefore, fine mapping of the neutralizing epitopes is important to clarify the relation of the hypervariable regions to the antigenicity of FCV. 
* Reactivity with the capsid protein of FCV strain F4. † MAbs were categorized into groups according to their reactivities against FCV strains and neutralization-resistant variants. 
* Nucleotide position in ORF2. † Deduced amino acid position in capsid precursor protein.
In this study, we cloned the capsid protein gene, especially the hypervariable regions of the gene of resistant variants by RT-PCR and sequenced the cloned cDNA to locate amino acid residues involved in the formation of neutralizing epitopes.
The MAbs and the neutralization-resistant variants used in this study were previously produced and characterized (Tohya et al., 1990 (Tohya et al., , 1991 , except for MAbs 10F9 and 16C10. Additional resistant variants were selected by the two MAbs and we examined their cross-reactivities against the MAbs used in this study. Since no resistant variants against MAb 1D7 were obtained in the previous study (Tohya et al., 1991) , we tried to select variants again in this study. However, we found no variants against MAb 1D7 in 10) n $ p.f.u. of parent virus. Properties of the MAbs including 10F9 and 16C10 are shown in Table 1 .
Total RNA was isolated from CRFK cells infected with each of the variants at 4 h post-infection by the acid guani- dium thiocyanate-phenol-chloroform extraction method (Chomczynski & Sacchi, 1987) . The RNA (1 µg) was reversetranscribed in the presence of antisense primer (5h TCCTC-GCCAATCCCAGTGTA 3h ; nucleotides 1613 to 1594 in ORF2 of FCV F4) with Moloney murine leukaemia virus reverse transcriptase (Gibco BRL). The synthesized cDNA was amplified by PCR (Saiki et al., 1988) using the antisense primer and sense primer (5h CATTTCGACTTTAACCAAGA 3h ; nucleotides 1117 to 1136 in ORF2). This primer set spans 1117 to 1613 in ORF2 of FCV F4 and results in a 497 bp product, which includes a sequence for amino acids 380 to 530 of the capsid precursor protein containing the hypervariable regions. The amplified DNA products were ligated into the TA cloning pCR vector of the TA Cloning System (Invitrogen). Both strands of the insert were analysed using a dye-primer Taq sequencing method and an autosequencer (ABI). For each of the variants, two clones obtained from separate PCR experiments were sequenced. A single point mutation responsible for each of the neutralizing epitopes was found in each of the resistant variants selected with a single MAb, except res16F7 (Table 2 ). Res16F7 and res10H2 were selected with similar MAbs and showed identical reactivity against a panel of MAbs (Tohya et al., 1991) . The resistance of these variants was considered to be induced by the common mutation at position 1481 (G to A). Therefore, the unique mutation at position 1550 (A to G) of res16H7 would be a spontaneous mutation of the singlestranded RNA virus and might not be responsible for the antigenic characteristics of the virus.
The amino acid substitutions of the resistant variants selected by MAbs of groups 3A, 3B, 3C and 4 were localized in the hypervariable region from amino acid 426 to 460 ( Table  2 ). The region was considered to correspond to an antigenic site of FCV composed of at least four linear and overlapping epitopes, which were characterized in our previous studies (Tohya et al., 1991 ; Shin et al., 1993) . The relative positions defined in this study agreed with the result of a crossneutralization test (Tohya et al., 1991) except for the two variant clones selected by 4B1. We expected different substitutions in the clones because they showed different reactivity against MAbs of group 3C (15H3 and 12C12). One of them may have an additional substitution undetected in the analysis.
The reactivities of three MAbs (4B1, 10F9 and 16C10) against 11 FCV strains including Japanese (F1, F5, F6, F8, F14 and F25) , American (FC, CFI and FPL), Swiss (337) and New Zealand (KCD) isolates were determined as neutralization index (NI) values. The virus titre (VT) of each FCV strain was examined in parallel in the absence (VT0) and presence (VTAb) of each diluted ascites (1 : 100). The NI value was calculated according to the formula : NI l log "! VT0klog "! VTAb. Although the mutations selected by the MAbs of group 3B (4B1, 10F9, 16C10) were identical in sequence analysis (Table  2) , their neutralization activities against several FCV strains were not identical ( Table 3 ), indicating that the epitope around amino acid 448 can induce antibodies with different affinities to FCV strains.
In the other hypervariable region from amino acid 490 to 520, two kinds of substitutions were determined (Table 2) . One (amino acid 493) was selected by MAbs of group 2B and the other (amino acid 494) by MAbs of group 2A. The MAbs were suggested to recognize conformational epitopes because of their inability to detect the capsid protein in an immunoblot under denaturing conditions (Table 1) . Although Seal (1994) found a great deal of heterogeneity from residues 490 to 495, it is uncertain what role the heterogeneity plays in serum-virus neutralization. This paper shows the first evidence indicating that this hypervariable region relates to neutralization of FCV. As the epitopes were shown to overlap functionally with each other (Tohya et al., 1991) , the region was considered to contain the second antigenic site of FCV, composed of at least two overlapping conformational epitopes.
The epitope recognized by MAb 1D7 was not mapped in this study because of the inability to isolate 1D7-resistant variants. It was considered that the 1D7 epitope might exist in a conserved region on the capsid protein because of the ability of 1D7 to neutralize all the strains of FCV tested (Tohya et al., 1991) . A highly conserved amino acid sequence (461 to 489) between the hypervariable regions contained a hydrophilic region of high surface probability according to computer analysis (Seal et al., 1993) . MAbs 1D7 might recognize a common neutralizing epitope of FCV in such a region.
In conclusion, two antigenic sites composed of clusters of overlapping epitopes were mapped in each of the hypervariable regions of the capsid protein of FCV. The location of antigenic sites involved in neutralization demonstrates the relationship between genetic variability in the capsid protein gene and the antigenic differences in neutralization of FCV.
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